Trying to figure out the commercialisation strategy here.
Basically Auricle is a company set up to commercialise Dr. Shore's work BUT:
1.) Is it just a company that intends to licence out the technology.
2.) Is it a company set up to handle all aspects of manufacture to distribution.
My thoughts are that it is 1.
Let's look at the basics.
The device is a simple device and manufacturing will be outsourced.
Who then will handle the distribution and promotion?
If it is a licensee, then it is quite possible we could see the device roll out much faster.
Plus, jurisdictions like the EU could see the device first if there is an agreement in place.
From Dr. Shore's perspective, surely building a company and rapid rollout will need significant capital, whereas Auricle as the licensing vehicle, will need to only handle manufacturing (outsourced) and enjoy revenue from two prime sources with limited capital investment: Revenue from device sale % and royalty payments.
This is my vision for commercialisation.
For example, in the EU, why would a company like Neuromod not cull its own device (Lenire) and license the MTD if it shows excellent results.
Neuromod has everything in place, marketing, brand, distribution.
Auricle potentially has what Lenire doesn't. A product that works!